Menu
Search
|

Menu

Close
X

Masimo Corp MASI.OQ (NASDAQ Stock Exchange Global Select Market)

86.68 USD
+0.74 (+0.86%)
As of Feb 17
chart
Previous Close 85.94
Open 85.77
Volume 135,256
3m Avg Volume 155,776
Today’s High 87.34
Today’s Low 85.75
52 Week High 104.71
52 Week Low 79.82
Shares Outstanding (mil) 51.94
Market Capitalization (mil) 4,526.06
Forward P/E 14.21
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.20 Mean rating from 5 analysts

KEY STATS

Revenue (mm, USD)
FY17
379
FY16
695
FY15
630
EPS (USD)
FY17
1.647
FY16
5.586
FY15
1.556
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
14.21
32.90
Price to Sales (TTM)
vs sector
6.20
5.77
Price to Book (MRQ)
vs sector
6.38
5.41
Price to Cash Flow (TTM)
vs sector
12.81
23.42
Total Debt to Equity (MRQ)
vs sector
0.00
16.52
LT Debt to Equity (MRQ)
vs sector
0.00
12.22
Return on Investment (TTM)
vs sector
54.37
14.43
Return on Equity (TTM)
vs sector
66.71
16.13

EXECUTIVE LEADERSHIP

Joseph Kiani
Chairman of the Board, Chief Executive Officer, Since 1989
Salary: $1,015,000.00
Bonus: --
Micah Young
Chief Financial Officer, Executive Vice President, Since 2017
Salary: --
Bonus: --
John Coleman
President - Worldwide Sales, Professional Services and Medical Affairs, Since 2013
Salary: $354,103.00
Bonus: --
Rick Fishel
President - Worldwide OEM Business & Strategic Development, Since 2015
Salary: $357,574.00
Bonus: --
Anand Sampath
Chief Operating Officer, Since 2014
Salary: $426,340.00
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Medical Equipment, Supplies & Distribution
Address:

52 Discovery
IRVINE   CA   92618-3105

Phone: +1949.2977000

Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company's business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry. Its product offerings include non-invasive monitoring of blood constituents with an optical signature, optical organ oximetry monitoring, electrical, brain function monitoring, acoustic respiration monitoring and exhaled gas monitoring. In addition, the Company has developed the Root patient monitoring and connectivity platform, the Radical-7 bedside and portable patient monitor, and the Radius-7 wearable wireless patient monitor. It offers Patient SafetyNet remote patient surveillance monitoring system, which allows patients to be monitored through a personal computer-based monitor or by care providers through their pagers, voice-over-Internet Protocol (IP) phones or smartphones.

SPONSORED STORIES